Review
Advances of long non-coding RNA in thyroid tumor
Yu Zhang, Jinwang Ding, You Peng, Xiaocheng Xu, Dingcun Luo, Daojun Yu, Qiaofeng Tu
Published 2016-08-25
Cite as Chin J Endocr Surg, 2016, 10(4): 336-339. DOI: 10.3760/cma.j.issn.1674-6090.2016.04.019
Abstract
Long non-coding RNA (lncRNA) is non-protein coding transcripts longer than 200 nucleotides, which plays an important role in the development of the metabolic process. Thyroid cancer is the most common cancer of the endocrine system, and as reported, lncRNA is related to the occurrence and development of thyroid tumors. Therefore, this paper reports the latest domestic and foreign research progress about lncRNA in thyroid tumor, in order to provide new ideas for molecular diagnosis and treatment of thyroid cancer.
Key words:
lncRNA; Thyroid tumor
Contributor Information
Yu Zhang
Department of Oncological Surgery, Hangzhou First People’s Hospital, Hangzhou 310006, China
Jinwang Ding
Department of Oncological Surgery, Hangzhou First People’s Hospital, Hangzhou 310006, China
You Peng
Department of Oncological Surgery, Hangzhou First People’s Hospital, Hangzhou 310006, China
Xiaocheng Xu
Department of Surgery of Thyroid and Breast, Wujiang District of Suzhou First People’s Hospital, Suzhou 215200, China
Dingcun Luo
Department of Oncological Surgery, Hangzhou First People’s Hospital, Hangzhou 310006, China
Daojun Yu
Department of Gene Diagnosis Laboratory, Hangzhou First People’s Hospital, Hangzhou 310006, China
Qiaofeng Tu
Department of Gene Diagnosis Laboratory, Hangzhou First People’s Hospital, Hangzhou 310006, China